SEC Form 4 · accession 0001547522-15-000188
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeremy M Jones
Director
Period of report
Dec 4, 2015
Accepted (ET)
Dec 9, 2015 · 8:13 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Dec 4, 2015 | J | 181,818 | $0.165 | A | 314,292 | D | |
| Common stock | holding | — | — | — | 132,474 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted shares of common stock acquired directly from the Company in a private transaction.